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Abstract
Background: Lidocaine is an approved local anesthetic and Class 1B antiarrhythmic with a number of ancillary
properties. Our aim was to investigate lidocaine’s vasoreactivity properties in intact versus denuded rat thoracic
aortic rings, and the effect of inhibitors of nitric oxide (NO), prostenoids, voltage-dependent Kv and KATP channels,
membrane Na+/K+ pump, and A2a and A2b receptors.
Methods: Aortic rings were harvested from adult male Sprague Dawley rats and equilibrated in an organ bath
containing oxygenated, modified Krebs-Henseleit solution, pH 7.4, 37 °C. The rings were pre-contracted sub-maximally
with 0.3 μM norepinephrine (NE), and the effect of increasing lidocaine concentrations was examined. Rings were
tested for viability after each experiment with maximally dilating 100 μM papaverine. The drugs 4-aminopyridine (4-AP),
glibenclamide, 5-hydroxydecanoate, ouabain, 8-(3-chlorostyryl) caffeine and PSB-0788 were examined.
Results: All drugs tested had no significant effect on basal tension. Lidocaine relaxation in intact rings was biphasic
between 1 and 10 μM (Phase 1) and 10 and 1000 μM (Phase 2). Mechanical removal of the endothelium resulted in
further relaxation, and at lower concentrations ring sensitivity (% relaxation per μM lidocaine) significantly increased 3.5
times compared to intact rings. The relaxing factor(s) responsible for enhancing ring relaxation did not appear to be
NO- or prostacyclin-dependent, as L-NAME and indomethacin had little or no effect on intact ring relaxation. In
denuded rings, lidocaine relaxation was completely abolished by Kv channel inhibition and significantly reduced by
antagonists of the MitoKATP channel, and to a lesser extent the SarcKATP channel. Curiously, A2a subtype receptor
antagonism significantly inhibited lidocaine relaxation above 100 μM, but not the A2b receptor.
Conclusions: We show that lidocaine relaxation in rat thoracic aorta was biphasic and significantly enhanced by
endothelial removal, which did not appear to be NO or prostacyclin dependent. The unknown factor(s) responsible for
enhanced relaxation was significantly reduced by Kv inhibition, 5-HD inhibition, and A2a subtype inhibition indicating a
potential role for crosstalk in lidocaine’s vasoreactivity.
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Background
Lidocaine is a local amide-type cationic anesthetic,
which acts by blocking voltage-dependent Na+ fast chan-
nels in excitable cells (EC50, 50–100 uM) [1]. At lower
concentrations, lidocaine is an approved Class 1B antiar-
rhythmic [2] and exerts anti-inflammatory [3], neuropro-
tective [4], energy-lowering [5], anti-ischemic [6, 7],
anti-oxidant [8, 9] and platelet-neutrophil interactive
[10, 11] properties.
Lidocaine has also been shown to exert a number of
vasomodulatory properties in isolated vessels including:
1) endothelium-independent relaxation [12, 13], and 2)
vascular smooth muscle relaxation [12, 14, 15] or con-
traction [15–19] properties. The apparent paradoxical
nature of lidocaine on vascular smooth muscle is often
explained as being dose-dependent with vasoconstriction
of peripheral blood vessels occurring at low concentra-
tions of lidocaine (~5 uM) and vasodilation at higher
levels (>50 uM) [14, 16, 20, 21]. In the rat carotid artery,
Kinoshita further proposed that lidocaine may impair
the vasodilator response via the activation of ATP-
sensitive K+ channels which may exacerbated by hypoxia
[19]. Earlier the same group showed that in pre-
contracted denuded rat aortic rings that acidification
promoted lidocaine relaxation and alkanization led to
vasoconstriction [18].
These confounding effects of lidocaine vasoreactivity
appear to be linked to differential modulation of mul-
tiple channels including Na+ channels [2], inwardly-
rectifying K+ channels [22], Ca2+ channels [13, 23] and/
or KATP channels [18, 19]. Vasodilation may involve ni-
tric oxide (NO) [24–26], redox regulation [9] and pos-
sible convergence of a multitude of downstream cAMP
and cGMP signalling cascades that lead to changes in
cytosolic Ca2+ [27]. Hollmann and colleagues, for
example, identified lidocaine and G-protein coupled
receptor systems as potential intracellular signalling
mechanisms, and the Gq protein subunit as a
possible common target [28]. In 2003, Benkwitz et
al., also showed that the Gi protein subunit was en-
hanced by lidocaine, and that it was potentiated ad-
enosine A1-receptor signalling [29]. The group
proposed that lidocaine was not an A1-receptor
agonist but enhanced adenosine-A1 receptor signal-
ling separate from its local anesthetic Na+ channel
properties [29]. The aim of the present study was to
investigate the nature of lidocaine relaxation in iso-
lated rat thoracic aortic rings, and examine the effect
of inhibitors of NO, prostenoids, Kv channels, KATP
channels, and adenosine A2a and A2b receptors.
Adenosine A2 receptors were chosen because they
are widely known to modify vascular tone [30], and




Male Sprague Dawley rats (300–350 g, n = 72) were fed
ad libitum and housed in a 12-h light/dark cycle. On the
day of the experiment rats were anaesthetised with Na-
thiopentone (100 mg/kg). Animals were treated in
accordance with the Guide for the Care and Use of
Laboratory Animals published by the US National Insti-
tutes of Health (NIH Publication No. 85-23, revised
1996). The James Cook University ethics approval num-
ber for the studies was A1535. Lidocaine hydrochloride
was sourced as a 2% solution (Ilium) from the local
Pharmaceutical Suppliers (Lyppard, Queensland). All
other chemicals, drugs and inhibitors were purchased
from Sigma Aldrich (Castle Hill, NSW).
Aortic ring preparation and organ bath tension
measurements
The thoracic cavity of anesthetized rats was opened and
the thoracic aorta was harvested and placed in a modi-
fied ice-cold solution of Krebs Henseleit (118 mM NaCl,
4.7 mM KCl, 1.2 mM Na2PO4, 0.5 mM MgCl2, 1.12 mM
CaCl2, 25 mM NaHCO3, 0.03 mM EDTA) pH 7.4 with
11 mM glucose. The aorta was carefully dissected from
surrounding fat and connective tissue and cut into short
transverse segments. Intact aortic rings were isolated
from each rat and used without further processing. In
those studies that required removal of the endothelium,
intact rings were denuded by gently rubbing the intimal
surface of the vessel segment with a smooth metal
probe. Successful removal of the endothelium was
assessed by testing the aortic ring for a vasodilatory re-
sponse to 10 μM acetylcholine (final concentration).
After preparation, intact or denuded aortic rings (3 to
4 mm long) were equilibrated in a standard 10 ml vol-
ume organ bath (Radnotti Glass, ADinstruments, NSW,
AUS) containing modified Krebs Henseleit (see above)
and continuously bubbled with 95% O2 and 5% CO2 at
37 °C for 15 min (zero tension) (Fig. 1). The rings were
vertically mounted on small stainless steel triangles, stir-
rups and connected to an isometric force transducer
(PANLAB, distributed by ADInstruments as MLT 0201/
RAD, NSW, AUS) coupled to a computer based data ac-
quisition system (PowerLab, ADInstruments) and data
recording software LabChart 7 (ADInstruments Pty Ltd.,
Castle Hill, Australia) (Fig. 1).
The ring tension was manually adjusted to 1.5 g and
equilibrated for 60 min. A tension of 1.5 g was chosen
from the literature for thoracic aortic rings prepared
from 300 to 400 g rats [18, 31] and preliminary studies
verified this tension. During equilibration, the solution
was changed in 15 min intervals. The aortic rings were
then washed with freshly prepared Krebs Henseleit buf-
fer pH 7.4 and the tension was readjusted to 1.5 g
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tension. Each preparation was sub-maximally contracted
using 3 μl of 0.1 mM NE (0.3 μM final concentration)
[15, 32]. Those aortic rings that failed to contract were
discarded. Ten microliters of 10 mM acetylcholine
(10 μM final concentration) was applied to confirm the
presence or absence of an intact endothelium in all
preparations. Acetylcholine will induce rapid relaxation
of precontracted rings if the endothelium is intact and if
the endothelium is removed (or denuded) the rings will
remain in contracted state [33]. Aortic rings were con-
sidered intact if the relaxation induced by 10 μM ACh
was greater than 80%, and the aortic ring was assumed
denuded if relaxation was less than 10%.
Rings were contracted at least two more times before
each experiment until a reproducible contractile re-
sponse was obtained. Ten to 15 min after this state was
achieved the experiment was commenced because pre-
liminary studies showed that the increase in tension and
plateau from 0.3 μM of NE was reached at 10 min and
remained at this plateau level for over 60 min, the time
course of each experiment.
Lidocaine relaxation in intact and denuded rat aortic
rings: a scheme of the experimental protocol
Lidocaine-HCl was added into the oxygenated organ
bath containing KH solution to obtain 1, 5, 10, 50, 100,
500 and 1000 μM lidocaine concentrations. The change
in tension of pre-contracted intact or denuded rings was
measured. Responsiveness was defined as % relaxation
per μM lidocaine. The inhibitors used in this study were
incubated in organ bath 20–30 min before NE was ad-
ministered followed by lidocaine incremental adminis-
tration. These included 1). 100 μM NG-nitro-L-arginine
Methyl Ester (L-NAME) (nitric oxide synthetase inhibi-
tor) and 10 μM indomethacin (cyclooxygenase or prosta-
glandin inhibitor e.g. prostacyclin). NO and prostacyclin
are two major endothelial derived relaxation factors
(EDRF), and the inhibitors were only applied in end-
othelium intact aortic rings. 2). 1 mM 4-aminopyridine
(4-AP) (Non-selective voltage-dependent K+-channel
blocker of the Kv1 to Kv4 families rather than Kv7 chan-
nels) [34–36], 10 μM glibenclamide (Non-selective
SarcKATP channel blocker) [37, 38] and 1 mM 5-
hydroxydecanoate (5-HD) (Non-selective MitoKATP
channel blocker) [39], and Na+/K+-ATPase inhibitor
(100 μM ouabain) [40]. While 5-HD is commonly used
in the literature as a specific MitoKATP channel blocker
[41], Hanley and colleagues have shown that 5-HD is
not a selective inhibitor of mitochondrial KATP channels
but can act a substrate for the mitochondrial outer
membrane enzyme acyl-CoA synthetase in the beta-
oxidation pathway [42]), and it is also capable of playing
a role as an inhibitor of sarcolemmal KATP channels in
the presence of ATP (which was not the case in our
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Fig. 1 A graphical scheme of the rat thoracic aorta ring apparatus for isometric force measurements, receptor sensitivity and smooth muscle-
endothelial interactions. See Methods for details
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study) [43]. These inhibitors were applied to intact endo-
thelium rings in the presence of L-NAME and indo-
methacin, and without the presence of L-NAME and
indomethacin in denuded aortic rings, and 3) The ad-
enosine A2a receptor inhibitor, 100 μM 8-(3-chlorostyryl)
caffeine (CSC) [44–46], and the A2b receptor inhibitor,
10 μM 8-(4-(4-(4-chlorobenzyl)piperazine-1-sulfonyl)-
phenyl)-1-propylxanthine (PSB-0788) [47]. These high
affinity antagonists have been used in rodent studies
with reported Ki values of 24 nM for CSC [48] and 0.393
nM for PSB-0788 [47]. CSC has also been shown to be
520-fold selective for A2a-adenosine receptors in radioli-
gand binding assays in the rat brain (Ki, 54 nM) with lit-
tle or no effect on A1 receptors [44]. The inhibitors
were applied to isolated rat aortic rings in an oxygenated
medium. At the end of each experiment, the rings were
tested for viability (or patency) by being maximally
dilated with 100 μM papaverine, and relaxation was
expressed as percentage of maximal relaxation to papa-
verine [40, 49].
Statistics
Values are expressed as mean ± SEM. The number of rats
was selected from a priori G-power analysis to achieve a
level of 1.0. Values are expressed as mean ± SEM. All data
was tested for normality using Kolmogorov-Smirnov test.
Relaxation responses to lidocaine were analysed for homo-
geneity of variances followed by two-way ANOVA
coupled with the Bonferroni post-hoc test for individual
data point comparisons. The alpha level of significance for
all experiments was set at p < 0.05.
Results
Effect of increasing lidocaine on relaxation in intact and
denuded rings
Intact rings
The gram tension produced with NE administration in
endothelium intact rings was not significantly different
from denuded aortic rings. Lidocaine produced a
concentration-dependent, biphasic relaxation relation-
ship in intact and denuded rat aortic rings (Fig. 2). The
percentage relaxation in intact rat aortic rings was 1.3,
6.0, 8.6 and 41.7% at 1, 10, 100 and 1000 uM lidocaine
respectively. The first relaxation phase was between 1
and 10 uM (Phase 1) and the second phase was from 10
to 1000 uM lidocaine (Phase 2) (log concentration scale)
(Fig. 2). The percentage relaxation per μM lidocaine
(ring responsiveness) was 0.47% from 1 to 10 μM,
0.029% between 10 and 100 μM and 0.037% increase per
μM between 100 and 1000 μM lidocaine. The maximum
relaxation from 1 to 1000 μM lidocaine in intact rings
was 40.4%.
Denuded rings
Removal of the endothelium significantly increased
Phase 1 relaxation responsiveness from 0.47 to 1.80%
per μM lidocaine between 1 and 10 μM (Fig. 2). Interest-
ingly, above 10 μM removing the endothelium had little
or no significant effect on ring responsiveness to in-
creasing lidocaine compared to intact rings. From 10 to
100 μM, % relaxation per μM was 0.033% and from 100
to 1000 μM was 0.028% (Fig. 2). However, despite this
similar responsiveness, at each lidocaine concentration
up to 100 μM, the absolute percentage relaxation was
significantly higher in denuded rings than intact rings.
The absolute % relaxation in denuded rings was 5.5, 14,
22, 24, 25, 36 and 50% at 1, 5, 10, 50, 100, 500 and 1000
uM lidocaine respectively (Fig. 2). Thus the effect of re-
moving the endothelium was to significantly enhance
ring sensitivity or responsiveness at lower lidocaine con-
centrations (1 to 10 μM) but not in the higher range (10
to 1000 μM), even though absolute relaxation values
were significantly higher at each lidocaine concentration
(1 to 1000 μM) in denuded versus intact rings (Fig. 2).
Effect of L-NAME and indomethacin in intact aortic rings
In intact aortic rings, pre-treatment with L-NAME and
indomethacin did not significantly change lidocaine relax-
ation from 1 to 1000 μM, although there was a trend to-
wards inhibition at higher concentrations (Fig. 3). Between
1 and 10 μM, the change in relaxation was 0.44% per μM,
0002% per μM between 10 and 100 μM and 0.029% per
μM from 100 to 1000 μM. At 500 μM lidocaine, the % re-
laxation was 17% (32% lower than intact rings) and at
Fig. 2 Concentration response curves to lidocaine in intact and
denuded isolated rat aortic rings. Relaxation is expressed as percent
of maximal relaxation to 100 μM papaverine. Points represent mean
± S.E.M of aortic rings. *P < 0.05 statistical difference in responses
between the intact and denuded rings. Lidocaine concentrations are
on a log scale. Total animals n = 12
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1000 μM lidocaine was 32% (24% lower than intact rings),
but the differences were not significant (Fig. 3).
Effect of Kv, SarcKATP, MitoKATP and Na
+/K+ ATPase
antagonists on relaxation in intact and denuded rings
The effects of voltage-dependent Kv, SarcKATP, mitoKATP
and Na+/K+-ATPase antagonists on lidocaine relaxation
in intact rat aortic rings are shown in Fig. 4. After pre-
contracted with NE, ring basal tensions were 3.3 ± 0.09 g;
3.5 ± 0.17 g; 3.4 ± 0.09 g; 3.4 ± 0.14 g (n = 8 each) for 4-AP,
glibenclamide, 5-HD and ouabain groups, respectively;
and not significantly different from NE with L-NAME and
indomethacin controls (3.2 ± 0.19 g, n = 8). In endothelial
intact aortic rings, exposure of rings to these antagonists
did not alter lidocaine-induced relaxation compared to
controls (Fig. 4).
In denuded rings, the effect of 1 mM 4-AP was to
totally abolish relaxation up to 500 μM after which
relaxation was 12 ± 5% (n = 8) compared to 39 ± 5% in
denuded controls (i.e. 4-AP led to a 70% decrease in
relaxtion) (Fig. 5a). 4-AP inhibition was significant
from 1 to 1000 μM lidocaine (p < 0.0001). The effect
of glibenclamide (10 μM) had little or no effect on
relaxation up to 10 μM lidocaine compared to de-
nuded controls (Fig. 5b) and was ~20% lower at
higher lidocaine concentrations; however, the differ-
ences were not significant. Exposure of denuded rings
to 1 mM 5-HD led to ~50% decrease in lidocaine re-
laxation at 5 to 1000 μM lidocaine which was signifi-
cant >50 μM (Fig. 5c). The presence of 100 μM
ouabain, a Na+/K+-ATPase channel inhibitor, had little
or no significant effect on lidocaine-induced relax-
ation (Fig. 5d).
Effect of A2a and A2b antagonists in intact and denuded
rat aortic rings
The basal tension of NE-precontracted CSC group was
3.1 ± 0.16 g and PSB-0788 groups 3.7 ± 0.07 g (n = 8 each)
and not significantly different from controls (3.2 ± 0.19 g,
n = 8). Adenosine A2a antagonist 8-(3-chlorostyryl) caf-
feine (CSC) significantly decreased lidocaine relaxation in
the intact rat aorta at 100 to 1000 μM (Fig. 6). Divergence
began to occur at 50 μM lidocaine with relaxation values
of 2, −2.8, −3.4 and 7.6% at 50, 100, 500 and 1000 μM
lidocaine respectively. In direct contrast, the incubation
with PSB-0788, an adenosine A2b antagonist, did not mod-
ify lidocaine-induced relaxation curve at any concentra-
tion used in NE pre-contracted aortic rings (Fig. 6).
In denuded rings, the basal tension of aortic rings with
the presence of CSC (2.5 ± 0.15 g) or PSB-0788 (3.1 ±
0.18 g) was not significantly different. CSC had no effect
on relaxation up to 10 uM lidocaine then strongly inhib-
ited relaxation up to 500 μM (Fig. 6). The maximum lido-
caine relaxation was 13 ± 6%, which was significantly
lower than control denuded rings (39 ± 5%, p < 0.0001)
(Fig. 6). The adenosine A2b receptor blocker PSB-0788
(10 μM) also decreased lidocaine relaxation by up to 50%
but this effect was not significant (Fig. 6). At 10, 100, and
1000 μM lidocaine, the relaxation percentages were 7 ± 1,
10 ± 2, and 31 ± 3%, respectively compared to 16 ± 3, 19 ±
4, and 39 ± 5% in denuded controls (Fig. 6).
Discussion
Despite decades of investigation, the mechanisms of
lidocaine relaxation in the rat thoracic aorta, and muscu-
lar resistance arterioles are not fully understood [12, 14–
16, 20, 21]. We report in isolated rat thoracic rings, pre-
contracted with NE, that lidocaine relaxation was: 1) bi-
phasic from 1 to 10 μM and 10 to 1000 μM, 2) signifi-
cantly enhanced by endothelial removal, particularly
from 1 to 100 μM, 3) not significantly affected in the
presence of L-NAME- and indomethacin in intact rings,
4) abolished by 4-AP in denuded rings and significantly
reduced by 5-HD, and to a lesser extent glibenclamide,
and 5) significantly reduced by A2a subtype antagonist
from 100 to 1000 μM, but not A2b. We discuss the pos-
sible physiological significance of the biphasic nature of
lidocaine relaxation, enhancement after endothelial re-
moval, and potential role for crosstalk with the A2a sub-
type and voltage-dependent Kv and KATP channels.
Lidocaine relaxation was biphasic and endothelial
dependent
We found in oxygenated, glucose-containing Krebs
Henseleit buffer, pH 7.4 at 37 °C: 1) little or no change in
relaxation in rat aortic rings at low lidocaine concentra-
tions, and 2) a strong endothelial dependence which en-
hanced relaxation after its removal (Fig. 2). The data
Fig. 3 Concentration-response curves to lidocaine with and without
the presence of L-NAME + indomethacin in intact isolated rat aortic
rings. Relaxation is expressed as percent of maximal relaxation to
100 μM papaverine. Points represent mean ± S.E.M of aortic rings.
*P< 0.05 statistically different in the presence of L-NAME+ indomethacin
compared to control on intact rings. Lidocaine concentrations are on a
log scale. Total animals n= 12
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suggest that the presence of an intact endothelium acted
like a “brake” to reduce lidocaine relaxation, and upon its
removal activated some putative factor to enhance relax-
ation. Our findings are in contrast with those reported in
rat cremaster skeletal muscle [14], epicardial porcine cor-
onary arteries [50], human radial arterial rings [51], hu-
man mammary arteries [52], and rabbit carotid arteries
[15, 53], where lidocaine at low levels potentiated vaso-
constriction, and at high concentrations led to relaxation.
Jembeck and Samuelson further reported in isolated rings
from radial arteries that lidocaine led to significantly
stronger contractions after the endothelium was mechan-
ically removed [51]. Reasons for the differences are not
clear at present but may relate to species, age, mode of
sacrifice, physiological state, pre-contractile conditions
activating different channels and receptors (e.g. alter-
ation of the membrane smooth muscle potential with
high K+ versus NE or phenylephrine to pre-contract
isolated rings), tissue preparation, different endothelial
removal procedures and possible damage, buffer con-
ditions, temperature, PO2 availability, and the se-
quence of drug additions and concentrations. Another
important difference is vessel type; we studied the rat
thoracic aorta, which is a large, highly elastic artery
that normally offers little resistance to flow but assists
in coupling the heart, as a pump and pressure-
generator, to the arterial system by changing aortic
compliance not resistance [54].
a b
c d
Fig. 4 Concentration-response curves to lidocaine with and without the presence of specific ion channel blockers in intact isolated rat aortic
rings. a In the presence of 1 mM 4-aminopyridine. b In the presence of 1 mM 5-Hydroxydecanoate. c In the presence of 10 μM glibenclamide.
d In the presence of 100 μM ouabain. Relaxation is expressed as percent of maximal relaxation to 100 μM papaverine. Points represent mean ±
S.E.M of aortic rings in the presence of L-NAME and indomethacin. *P < 0.05 statistical difference in responses between the presence and the
absence of inhibitors on intact rings. Lidocaine concentrations are on a log scale. Total animals n = 16
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That lidocaine relaxation occurred from 1 to 1000 uM is
consistent with the study of Shan and colleagues who
showed that lidocaine relaxed phenylephrine or KCl
(60 mM) precontracted rat aortic rings in a concentration-
dependent manner [13]. However, their study differed from
ours because they showed lidocaine relaxation was not sig-
nificantly modified by endothelium removal, and their aor-
tic rings were obtained from rats sacrificed by stunning and
cervical dislocation, not anesthesia [13]. Our study also
agreed with Turan and colleagues who showed lidocaine
relaxed phenylephrine-precontracted rabbit thoracic aorta
intact and denuded rings, however, when lidocaine (1 to
100 μM) was applied 15 min before the addition of phenyl-
ephrine it produced contractions at high concentrations
(up to 10 mM), and endothelium removal did not signifi-
cantly affect contractile activity. This example demonstrates
the dynamics of the pre-contractile state and the import-
ance of specifying the sequence of drug administration,
which can produce different results. Further studies are
required to investigate these discrepancies in the thoracic
aorta of rat and other species prepared from different
modes of sacrifice, different precontracted states and basal
tone.
Lidocaine relaxation enhancement involves an
endothelium-smooth muscle coupling and possible acti-
vation of Kv and KATP channels
Since lidocaine relaxation displayed a strong endothelial-
dependence (Fig. 2), it suggested a possible role for NO
release or activation of the cyclo-oxygenase pathway
and/or their interactions with the adrenoreceptors on
vascular smooth muscle. Surprisingly, we found little or
no effect of either L-NAME and indomethacin on lido-
caine relaxation (Fig. 3) indicating that the putative
relaxing factor after endothelial removal was neither NO





Fig. 5 Concentration-response curves to lidocaine with and without the presence of specific ion channel blockers in denuded isolated rat aortic
rings. a In the presence of 1 mM 4-aminopyridine. b In the presence of 1 mM 5-Hydroxydecanoate. c In the presence of 10 μM glibenclamide.
d In the presence of 100 μM ouabain. Relaxation is expressed as percent of maximal relaxation to 100 μM papaverine. Points represent mean ±
S.E.M of aortic rings in the presence of L-NAME and indomethacin. *P < 0.05 statistical difference in responses between the presence and the
absence of inhibitors on intact rings. Lidocaine concentrations are on a log scale. Total animals n = 16
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released upon endothelial removal to enhance lidocaine
relaxation. Another possibility is endothelial-dependent
activation of smooth muscle voltage-dependent Kv chan-
nels and/or smooth muscle mitochondrial KATP chan-
nels, since we showed that 4-AP completely abolished
relaxation (Figs. 3a and 4a) and 5-HD led to ~50% inhib-
ition in denuded rings (Figs. 4c and 5c).
Enhanced lidocaine relaxation may also have come from
changing the cellular redox state and reactive oxygen spe-
cies (ROS) derived from NAD(P)H oxidases [55, 56], as it
has been reported that lidocaine at higher concentrations
protects against ROS attack in rabbit abdominal aorta [9].
Rogers and colleagues further showed that 4-AP-sensitive
Kv channels are redox sensitive and contribute to H2O2-
induced coronary vasodilation [57]. In summary, we con-
clude that enhanced lidocaine relaxation after endothelial
removal does not appear to involve the direct activation of
NO or prostanoid-linked pathways, and that other relax-
ing factors and downstream signalling pathways, possibly
involving Kv and/or 5-HD sensitive KATP channels, are
involved.
Smooth muscle adenosine A2a modulation may also be
involved in the enhanced lidocaine relaxation
The present study also suggests an intriguing possibility
for enhancing lidocaine relaxation may be activation of
the A2a receptor on vascular smooth muscle. A surpris-
ing result was that lidocaine relaxation above 50 μM in
intact and denuded rat aortic rings was significantly
inhibited by 75 to 100% in the presence of A2a blocker
8-(3-chlorostyryl) caffeine (CSC) (Fig. 5). This implies
that the A2a receptor may be involved in the presence or
Fig. 6 Concentration-response curves to lidocaine with and without the presence of adenosine A2ab receptor blockers in intact and denuded
isolated rat aortic rings. a (Adenosine A2a receptor antagonist) In the presence of 100 μM 8-(3-Chlorostyryl) caffeine. b (Adenosine A2b receptor
antagonist) In the presence of 10 μM PSB-0788. Relaxation is expressed as percent of maximal relaxation to 100 μM papaverine. Points represent
mean ± S.E.M of aortic rings in the presence of L-NAME and indomethacin. *P < 0.05 statistical difference in responses between the presence and
the absence of inhibitors on intact rings. Lidocaine concentrations are on a log scale. Total animals n = 16
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absence of an intact endothelium. Assuming CSC has
high specificity for A2a receptors [44], this antagonist
may reduce lidocaine relaxation from one or more of the
following mechanisms: 1) Directly or indirectly increas-
ing Ca2+ influx from extracellular sources such as L-type
Ca2+ channels [58], 2) increasing the release of Ca2+
from intracellular stores (e.g. sarcoplasmic or endoplas-
mic) to increase cytosolic free Ca2+, and/or 3) increasing
myofibrillar contractile sensitivity to existing free Ca2+
(signalled via the RhoA/Rho kinase pathway), increase
cross-bridge cycling and development of force [55, 59].
Possible crosstalk between A2a receptors and lidocaine
may also involve transmembrane domains of adenyl cy-
clase and other downstream signalling pathways to alter
intracellular free Ca2+ and/or myofibrillar sensitisation.
To our knowledge, little or no data exist on adenosine
and lidocaine interactions in intact rat aortic rings or
endothelial-vascular smooth muscle interactions. Adeno-
sine A2a and A2b receptors are present on vascular endothe-
lium and smooth muscle of many vessels [60, 61] and when
activated can lead to vasodilation. A2a receptor vasodilation
is thought to involve: 1) endothelial NO production which
activates smooth muscle guanylyl cyclase via opening Kir
channels [61], and/or 2) more direct smooth muscle A2a re-
ceptor activation which in turn stimulates mostly Gs pro-
teins (and Gq) and cAMP signalling pathways to reduce
intracellular Ca2+ levels [61, 62]. In addition, adenosine A2a
activation may activate sarcolemma Ca2+ channels and
regulate influx in large elastic arteries and resistance vessels.
Stella and colleagues showed that activation of A2 receptors
stimulates protein kinase A to inhibit L-type Ca2+ channels
in rod photoreceptors resulting in a decreased Ca2+ influx
[63]. Gubitz and colleagues have proposed dual A2a signal-
ling involving the activation of both N- and P-type calcium
channels by different G proteins and protein kinases in the
some nerve terminals [64]. Gonvalves and colleagues
showed that adenosine A2a receptors facilitated Ca
2+ uptake
through class A calcium channels in rat hippocampal CA3
region [65].
Interestingly, Benkwitz and colleagues also showed
that higher concentrations of lidocaine (1000 uM) in
hamster oocytes potentiated Galphai-coupled A1 recep-
tor signalling by reducing cyclic AMP production in a
dose-dependent manner through an unidentified mech-
anism [29]. The authors proposed that lidocaine was not
an A1-receptor agonist but enhanced adenosine-A1 receptor
signalling. They argued that lidocaine interacted with a pool
of already activated Gαi present in the cytoplasm and
thereby facilitated its ability to inhibit adenylate cyclase
leading to lower cAMP [29]. We did not examine adeno-
sine A1 receptor antagonism We conclude from our study
that A2a receptor may have enhanced lidocaine relaxation
activation by directly effecting vascular smooth muscle
(Fig. 6), and this may have occurred by reducing
intracellular Ca2+ and/or myofibrillar contractile sensitization
in intact isolated rat aortic rings, although the underlying
mechanisms remain to be identified. Further studies are
required to investigate the role of adenosine and lidocaine
on membrane Ca2+ channel modulation in isolated rat
aortic rings.
Limitations of the study and possible physiological
significance
The present study examined lidocaine relaxation in iso-
lated rat thoracic rings using length-tension experiments
and a number of antagonists of NO, prostanoids, Kv,
KATP and A2 receptors under normoxic and normal pH
conditions from healthy rats. Before definitive conclu-
sions can be drawn regarding the nature of unknown re-
laxation factor(s), it would be important to examine
separately and in combination other drug antagonists
and agonists of NO, prostanoids, Kv, Sarc- and Mito-
KATP channels and A2 receptors on lidocaine relaxation
in intact and denuded rings. Furthermore, to gain
greater mechanistic insight into the nature of voltage-
dependent K+ channels and lidocaine vasorelaxation
electrophysiological experiments would be essential.
Leukotrienes, and leukotriene synthase inhibitors, may
also be of interest because they have been shown to
modulate rat aortic ring relaxation [66]. Possible physio-
logical significance of the present study relates to lido-
caine’s effect to regulate in vivo compliance such as
ventricular-arterial coupling functions linking the heart
as a pump to tissue perfusion [67, 68]. However, further
in vivo studies are required to test this hypothesis. Also
our work may have clinical applicability on the ancillary
properties of lidocaine at the site of injection during in-
filtration, nerve block, or epidural anesthesia [14], and
on damaged endothelium such as in plaque formation,
arterial and venous conduit protection for cardiopulmo-
nary bypass grafting [69], prevention of vascular spasm
during neurosurgery [70], lowering elevated intracranial
pressure [71], lidocaine cardioplegia [72, 73], and other
surgical applications [54].
Conclusions
We showed in isolated, oxygenated NE precontracted
rat aortic rings that lidocaine relaxation was biphasic
from 1 to 10 uM and 10 to 1000 uM. We further
showed that lidocaine relaxation was significantly en-
hanced by endothelial removal, which did not appear to
be NO or prostacyclin dependent. The putative un-
known factor(s) responsible for enhanced relaxation may
involve activation of smooth muscle voltage-sensitive Kv
and 5-HD sensitive channels or pathways, and possible
crosstalk with A2a subtype receptor at higher lidocaine
concentrations.
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